Ledger.Open graph →
SEC Form D · filed April 24, 2014

Kala Pharmaceuticals, Inc

Offering
$22.5M
Sold
$22.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Darren J. Kottle · San Francisco, CAExecKim I. Halvorsen · LOS ANGELES, CADirectorMichael I. Iscove · LOS ANGELES, CADirectorAdam Mendelsohn · Emeryville, CADirectorDavid L. Rensink · SIOUX FALLS, SDDirectorBernard Gilly · Waltham, MADirectorKathleen Fischer · Emeryville, CADirectorW. D. Baker · Emeryville, CADirectorAaron Mendelsohn · Emeryville, CADirectorLily Peng · Emeryville, CAExecKarey Barker · Salt Lake City, UTDirectorJoseph M. Stanford · Brandon, SDDirectorGuillaume Pfefer · Waltham, MAExec · DirectorBernard Gilly · Paris, I0Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗